Order: Romazicon 0.3 mg IVP Available: a. 0.33 mL b. 3 mL c. 4 mL d. 2 ...

Author Question: Order: Romazicon 0.3 mg IVP Available: a. 0.33 mL b. 3 mL c. 4 mL d. 2 ... (Read 33 times)

Metfan725

Hero Member
Posts: 552

on: Jul 3, 2018

Order: Romazicon 0.3 mg IVP Available:

a. 0.33 mL
b. 3 mL
c. 4 mL
d. 2 mL

Question 2

Order: Morphine sulfate 4 mg IVP Available:

a. 2 mL
b. 2.5 mL
c. 0.4 mL
d. 1.5 mL

asware1

Sr. Member
Posts: 318

Reply #1 on: Jul 3, 2018

Answer to Question 1

ANS: B

Answer to Question 2

ANS: C

Need homework help now?

Ask unlimited questions for free

Ask a Question

Metfan725

Hero Member
Posts: 552

Reply #2 on: Jul 3, 2018

Correct answers!

asware1

Sr. Member
Posts: 318

Reply #3 on: Jul 3, 2018

Great! Please up vote

« previous next »

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.